PTU - Polskie Towarzystwo Urologiczne
list of articles:

FORTECORTIN IN CONSERVATIVE TREATMENT OF PEYRONIE'S DISEASE
Article published in Urologia Polska 1997/50/1.

authors

Barbara Darewicz, Janusz Darewicz, Tadeusz Werel
Klinika Urologii AM w Białymstoku
Kierownik Kliniki: prof. dr hab. med. J. Darewicz

keywords

penis Peyronie's disease local steroid therapy

summary

Objective: The oim of the study was to established the influence of the local use of the
Fortecortin in the treatment of the Peyronie's diesease.
Materials and method: The group of 23 patients with Peyronie's disease was treated
with local injectionis of Fortecortin. The injectionis were gives every 4 weeks for 6 months.
Results: 10 patients (43,%) were cured. In 9 patients in whom the improvement was
found the relief of pain during intercourse, reduction of penile curvature, erectile
improvement and decrease of plaque diameter were observed. 4 patients didn't notice any
change.
Conclusion: The authors belive that Fortecortin is a useful drug in conservative treatment
of the early forms of the Peyronie's disease.

references

  1. [1] Carson, C. C: Francois Gigot de la Peyronie. lnvest. Urol., 1981, 19, 62-63
  2. [2] Darewicz, J., Werel, T., Darewicz, B., Gałek, L.: Ocena wyników leczenia pacjen-
  3. tów z chorob± Peyronie po zastosowaniu miejscowych iniekcji orgoteiny. Urol. Pol.,
  4. 48, 214-216
  5. [3] DeSanctis, P. N., Furey, C. A. Jr.:: Steroid injection therapy for Peyronie 's disease:
  6. a 10 year Summary and review of 38 cases. J. Urol., 1967, 97, 114-116
  7. [4] Furey, C. A. Jr.: Peyronie s disease treatmant by the local injection of meticortelo-
  8. ne and hydrocortisonu J. Urol., 1957, 77, 251-266
  9. [5] Gelbard, M. K.., Hayden, B.: Expanding contractures of the tunica albuginea due to
  10. Peyronie s disease with temporalis fascia free grafts. J. Urol. 1991, 145, 112?IIb
  11. [6] Horton, C. E., Sadove, R. C, Devine, C. J. Jr.: Peyronie s disease. Ann. Piast.
  12. Surg., 1987, 18, 121-127
  13. [7] Nyberg, L. M. Jr., Bias, W. B., Hochberg, M. C, Walsh, P. C: Identification of an
  14. inherent form of Peyronie s disease with autosomal dominant inheritance and as-
  15. sociation with Dupuytren s contracture and histocompatibility B7 cross-reacting
  16. antigens. J. Urol., 1982, 128, 48-51
  17. [8] Vande Berg J. S., Devine C. J. Jr., Horton C. E., Somers K. D., Wright G. L. Jr.,
  18. Leffel M. S., Dawson D. M., Gleischman S. H., Rowe M. J.: Peyronie 's disease: an
  19. electron microscopic study. J. Urol., 1981, 126, 333 - 336.
  20. [9] Williams, G., Green, N. A.: The non-surgical treatment of Peyronie's disease.
  21. Br. J. Urol., 1980,52, 392-395
  22. [10] Winter, C. C, Khana, R.: Peyronie's disease: results with dermo-jet injection of
  23. dexametazone. J. Urol., 1975," 114, 898-900